Showing results (1851-1860 of 1,910) with videos related to
Sort By:
Pageof 191
Advanced Healthcare Materials|June 30, 2021
Versatile Nanodrugs Containing Glutathione and Heme Oxygenase 1 Inhibitors Enable Suppression of Antioxidant Defense System in a Two-Pronged Manner for Enhanced Photodynamic TherapyHao Zhong, Pei-Ying Huang, Ping Yan, et al.Journal of Virology|December 8, 2021
Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 InfectionYudi Zhang, Qihong Yan, Kun Luo, et al.Journal of Zhejiang University. Science. B|May 20, 2020
Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, ChinaJiang-Shan Lian, Huan Cai, Shao-Rui Hao, et al.Molecular Cancer Therapeutics|September 27, 2017
Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in GlioblastomaSani H Kizilbash, Shiv K Gupta, Kenneth Chang, et al.Veterinary Journal (London, England : 1997)|May 19, 2026
A Chimeric PRRSV Vaccine with Dual Nsp2 Deletions Elicits Cross-Lineage Protection Against Heterologous ChallengeZhuo-Ran Miao, Bo Han, Ling-Zhai Meng, et al.Signal Transduction and Targeted Therapy|April 17, 2023
Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variantsQian Wang, Chenchen Yang, Li Yin, et al.Infectious Diseases of Poverty|July 10, 2020
Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, ChinaShan-Yan Zhang, Jiang-Shan Lian, Jian-Hua Hu, et al.Scientific Reports|July 15, 2021
Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitorMichael C Babcock, Christina R Mikulka, Bing Wang, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 27, 2024
Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2/TFEB aix to inhibit autophagic fluxYong-Chun Peng, Zhi-Jing He, Lun-Cai Yin, et al.Bioorganic & Medicinal Chemistry Letters|March 13, 2008
Pyrimidine-based inhibitors of CaMKIIdeltaBabu Mavunkel, Yong-Jin Xu, Bindu Goyal, et al.Pageof 191